{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:19:32Z","timestamp":1778177972009,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.critrevonc.2011.04.006","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T18:05:37Z","timestamp":1307556337000},"page":"150-158","source":"Crossref","is-referenced-by-count":16,"title":["Place of modern imaging modalities for solitary plasmacytoma: Toward improved primary staging and treatment monitoring"],"prefix":"10.1016","volume":"82","author":[{"given":"Cyrus","family":"Chargari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Vennarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Servois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Bonardel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Lahutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Fourquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Bouscary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlia M.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2011.04.006_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1200\/JCO.1983.1.4.255","article-title":"Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone","volume":"1","author":"Knowling","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/PAP.0b013e31817cfcd6","article-title":"Multiple myeloma and immunosecretory disorders: an update","volume":"15","author":"Shaheen","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3324\/haematol.11133","article-title":"Demonstration of changes in plasma cell subsets in multiple myeloma","volume":"92","author":"Ayliffe","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0020","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/1097-0142(19810801)48:3<845::AID-CNCR2820480330>3.0.CO;2-E","article-title":"Solitary myeloma: clinical and prognostic features of a review of 114 cases","volume":"48","author":"Bataille","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0167-8140(99)00114-0","article-title":"Clinical course of solitary extramedullary plasmacytoma","volume":"52","author":"Liebross","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0167-8140(90)90003-F","article-title":"The role of radiation therapy in the treatment of solitary plasmacytomas","volume":"17","author":"Mayr","year":"1990","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0035","first-page":"101","article-title":"Radiotherapy in the management of plasma cell tumors","volume":"14","author":"Hu","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2407-6-118","article-title":"Rare Cancer Network. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study","volume":"6","author":"Knobel","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0045","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1118\/1.596958","article-title":"Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy","volume":"20","author":"Mackie","year":"1993","journal-title":"Med Phys"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1148\/rg.284075156","article-title":"Diagnostic imaging of solitary tumors of the spine: what to do and say","volume":"28","author":"Rodallec","year":"2008","journal-title":"Radiographics"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2214\/ajr.175.1.1750261","article-title":"The \u201cmini brain\u201d: plasmacytoma in a vertebral body on MR imaging","volume":"175","author":"Major","year":"2000","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/crad.2000.0440","article-title":"Magnetic resonance imaging of spinal plasmacytoma","volume":"55","author":"Shah","year":"2000","journal-title":"Clin Radiol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(96)00334-3","article-title":"Solitary plasmacytoma of bone and soft tissue","volume":"36","author":"Bolek","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0070","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00005537-199706000-00007","article-title":"Head and neck manifestations of plasma cell neoplasms","volume":"107","author":"Nofsinger","year":"1997","journal-title":"Laryngoscope"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0250","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.7863\/jum.2005.24.7.1031","article-title":"Sonographic Diagnosis of a Tracheal Extramedullary Plasmacytoma","volume":"24","author":"Reyhan","year":"2005","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2003-43327-1","article-title":"Skull base plasmacytoma in a patient with light chain myeloma","volume":"13","author":"Ustuner","year":"2003","journal-title":"Skull Base"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1182\/asheducation-2005.1.373","article-title":"Solitary bone and extramedullary plasmacytoma","author":"Weber","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0090","unstructured":"Sasaki R, Yasuda K, Abe E, et al. Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy. Int J Radiat Oncol Biol Phys; in press."},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0360-3016(89)90008-4","article-title":"Solitary plasmacytoma of bone: Mayo clinic experience","volume":"16","author":"Frassica","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0100","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.10366","article-title":"Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone","volume":"94","author":"Wilder","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0360-3016(00)01572-8","article-title":"Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome","volume":"50","author":"Tsang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","article-title":"Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma","volume":"124","author":"Guidelines Working Group of the UK Myeloma Forum (UKMF)","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0115","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","article-title":"Solitary plasmacytoma of bone and asymptomatic multiple myeloma","volume":"96","author":"Dimopoulos","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0120","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X","article-title":"Plasmacytoma. Treatment results and conversion to myeloma","volume":"69","author":"Holland","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.annonc.a059285","article-title":"Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?","volume":"6","author":"Galieni","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/bjc.1995.26","article-title":"Comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone","volume":"71","author":"Shih","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-5223(19)33852-8","article-title":"Medical tumors of the chest wall: solitary plasmacytoma and Ewing's sarcoma","volume":"105","author":"Burt","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0140","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/1097-0142(19880415)61:8<1707::AID-CNCR2820610832>3.0.CO;2-N","article-title":"Solitary plasmacytoma of the spine. Long-term clinical course","volume":"61","author":"Delauche-Cavallier","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1200\/JCO.1983.1.4.255","article-title":"Comparison of extramedullary plasmacytoma with solitary and multiple plasma cell tumours of bone","volume":"1","author":"Knowling","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0609.2009.01251.x","article-title":"Solitary plasmocytoma: improvement in critical organs sparing by means of helical tomotherapy","volume":"83","author":"Chargari","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0155","unstructured":"Chargari C, Hijal T, Caussa L, et al. The role of helical tomotherapy in the treatment of plasmacytoma lesions. Med Dosim; in press."},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2214\/AJR.04.1787","article-title":"Radiologic manifestations of primary solitary extramedullary and multiple solitary plasmacytomas","volume":"186","author":"Ooi","year":"2006","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0165","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1200\/JCO.1993.11.7.1311","article-title":"Magnetic resonance imaging in the staging of solitary plasmacytoma of bone","volume":"11","author":"Moulopoulos","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0170","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur-Melnyk","year":"2008","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00277-008-0621-6","article-title":"Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy","volume":"88","author":"Dinter","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0180","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2009.89","article-title":"IMWG. International Myeloma Working Group Consensus Statement and Guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma","volume":"23","author":"Dimopoulos","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0185","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiol.09090629","article-title":"Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging","volume":"254","author":"Lin","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1148\/rg.301095066","article-title":"Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET\/CT","volume":"30","author":"Hanrahan","year":"2010","journal-title":"Radiographics"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0195","unstructured":"Haznedar R, Ak\u0131 SZ, Akdemir OU, et al. Value of (18)F-fluorodeoxyglucose uptake in positron emission tomography\/computed tomography in predicting survival in multiple myeloma. Eur J Nucl Med Mol Imaging; in press."},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0200","first-page":"1457","article-title":"Whole-body (18)F-FDG PET identifies high-risk myeloma","volume":"43","author":"Durie","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","article-title":"A prospective comparison of 18Ffluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/108497803770418382","article-title":"Positron emission tomography (PET) for staging of solitary plasmacytoma","volume":"18","author":"Schirrmeister","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00259-001-0711-3","article-title":"Initial results in the assessment of multiple myeloma using 18F-FDG PET","volume":"29","author":"Schirrmeister","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0220","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3324\/haematol.12654","article-title":"FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma","volume":"93","author":"Salaun","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0225","first-page":"513","article-title":"18F-FDG PET\/CT in myeloma with presumed solitary plasmocytoma of bone","volume":"22","author":"Nanni","year":"2008","journal-title":"In Vivo"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0230","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00256-006-0127-z","article-title":"Comparison of imaging with FDG PET\/CT with other imaging modalities in myeloma","volume":"35","author":"Breyer","year":"2006","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0235","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ijrobp.2008.08.037","article-title":"Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma","volume":"74","author":"Kim","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PET\/CT, 99mTc-MIBI, and MRI in Evaluation of Patients with Multiple Myeloma","volume":"49","author":"Fonti","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.critrevonc.2011.04.006_bib0245","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00109889?term=NCT00109889&rank=1."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842811001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842811001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T23:42:56Z","timestamp":1592610176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842811001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1040842811001156"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2011.04.006","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}